A new trading day began on Friday, with Ovid Therapeutics Inc (NASDAQ: OVID) stock price up 9.20% from the previous day of trading, before settling in for the closing price of $1.63. OVID’s price has ranged from $0.24 to $2.01 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 24.72% over the past five years. Meanwhile, its annual earnings per share averaged -28.29%. With a float of $59.63 million, this company’s outstanding shares have now reached $71.15 million.
Ovid Therapeutics Inc (OVID) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ovid Therapeutics Inc is 16.27%, while institutional ownership is 40.38%. The most recent insider transaction that took place on Feb 26 ’25, was worth 2,956. In this transaction President and COO of this company sold 5,279 shares at a rate of $0.56, taking the stock ownership to the 73,406 shares. Before that another transaction happened on Feb 26 ’25, when Company’s CBFO sold 3,902 for $0.56, making the entire transaction worth $2,185. This insider now owns 67,973 shares in total.
Ovid Therapeutics Inc (OVID) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.13 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.20% during the next five years compared to 24.72% growth over the previous five years of trading.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
Here are Ovid Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Ovid Therapeutics Inc (OVID)
Ovid Therapeutics Inc (NASDAQ: OVID) saw its 5-day average volume 2.52 million, a positive change from its year-to-date volume of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 94.43%.
During the past 100 days, Ovid Therapeutics Inc’s (OVID) raw stochastic average was set at 86.06%, which indicates a significant decrease from 96.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1297 in the past 14 days, which was higher than the 0.1203 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4763, while its 200-day Moving Average is $0.7643. Nevertheless, the first resistance level for the watch stands at $1.8628 in the near term. At $1.9457, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0863. If the price goes on to break the first support level at $1.6393, it is likely to go to the next support level at $1.4987. The third support level lies at $1.4158 if the price breaches the second support level.
Ovid Therapeutics Inc (NASDAQ: OVID) Key Stats
With a market capitalization of 126.76 million, the company has a total of 71,212K Shares Outstanding. Currently, annual sales are 570 K while annual income is -26,430 K. The company’s previous quarter sales were 130 K while its latest quarter income was -12,160 K.
